THE rapidly spreading Zika virus, implicated in microencephaly, has been found to not cause contamination problems in plasma or urine-derived products, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has found.
The CHMP concluded at its meeting last week that the manufacturing processes for plasma-derived products, including for example the solvent/detergent method to inactivate viruses, pasteurisation (liquid heat inactivation) and virus filtration, inactivate or remove the Zika virus from the finished product.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Sep 16
